These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-000969-37 IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome (Dose Escalation Study: Varespladib Infusion [A-001] for the Prevention of Acute Chest Syndrome in At-Risk Pat... not-yet-due
Not reported 2009-016812-18 Evaluacion de la seguridad y eficacia del tratamiento a corto plazo con A-002 en sujetos con sindromes coronarios agudos Evaluation of the safety and efficacy of short-term A-002 treatment in subjects... 2012-05-15 due-trials
Not reported 2014-001365-26 A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects with IgA Nephropathy 2017-05-26 due-trials
Not reported 2015-002739-17 A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreat... 2017-01-17 due-trials
Not reported 2016-002851-92 An Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis 2018-03-27 due-trials
Not reported Terminated 2017-000571-85 A Phase 3, Randomized, Open-Label, Assessor-Blind, Non-Inferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreat... 2018-03-26 due-trials